Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glycemic response trajectories on metformin monotherapy in real-world diabetes care.

medRxiv : the preprint server for health sciences·2026
Same author

Robust ranking of renewable energy alternatives handling uncertainty using novel hesitant bi-fuzzy MEREC-MOORA and Dombi aggregation approach.

Scientific reports·2026
Same author

The Impact of Social Vulnerability on Exercise Outcomes: A Longitudinal Study of Physical Function in Older People With HIV.

Journal of the International Association of Providers of AIDS Care·2026
Same author

Special issue: cell and gene causal inference in the design and analysis of gene therapy clinical trials.

Journal of biopharmaceutical statistics·2026
Same author

Mapping the last mile: Micro-stratification for sustained visceral leishmaniasis elimination in Bangladesh.

PLoS neglected tropical diseases·2026
Same author

The effects of high-intensity interval training versus continuous moderate-intensity exercise on body composition among older adults with HIV.

The journals of gerontology. Series A, Biological sciences and medical sciences·2026
Same journal

Bandwidth of gamma-distribution-shaped functions via Lambert W function.

Statistics & probability letters·2026
Same journal

Directional replicability: When can the factor of two be omitted.

Statistics & probability letters·2026
Same journal

Approximating win-loss probabilities based on the overall and event-free survival functions.

Statistics & probability letters·2025
Same journal

On exact Bayesian credible sets for discrete parameters.

Statistics & probability letters·2025
Same journal

On critical points of Gaussian random fields under diffeomorphic transformations.

Statistics & probability letters·2024
Same journal

Universally Consistent K-Sample Tests via Dependence Measures.

Statistics & probability letters·2024
See all related articles

Related Experiment Video

Updated: May 19, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

A causal framework for surrogate endpoints with semi-competing risks data.

Debashis Ghosh1

  • 1Departments of Statistics and Public Health Sciences, The Pennsylvania State University, 514A Wartik Building, University Park, PA,16802 U.S.A.

Statistics & Probability Letters
|August 18, 2012
PubMed
Summary
This summary is machine-generated.

This study introduces an econometric causal modeling framework for surrogacy, differing from standard biostatistical approaches. It highlights direct effects and a key non-identifiability result in surrogate endpoint analysis.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Related Experiment Videos

Last Updated: May 19, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Area of Science:

  • Causal inference
  • Biostatistics
  • Econometrics

Background:

  • Surrogacy is a key concept in clinical trials for evaluating treatment efficacy.
  • Biostatistical literature predominantly uses the potential outcomes model for surrogacy.
  • Existing models face challenges with complex data structures like semi-competing risks.

Purpose of the Study:

  • To propose a novel causal modeling framework for surrogacy analysis.
  • To conceptualize direct effects of surrogate endpoints on true endpoints.
  • To investigate the identifiability of causal effects within this new framework.

Main Methods:

  • Utilizing an econometric causal modeling framework.
  • Conceptualizing direct effects from surrogate to true endpoints.
  • Deriving a fundamental non-identifiability result.

Main Results:

  • The proposed framework offers an alternative to potential outcomes models.
  • Direct effects of surrogate endpoints are explicitly modeled.
  • A significant non-identifiability result is established for surrogate endpoint analysis.

Conclusions:

  • The econometric framework provides new insights into surrogacy.
  • The non-identifiability result has critical implications for interpreting surrogate endpoints.
  • Further research is needed to explore relationships with existing causal models.